Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis-Reference-Cited by-同舟云学术

Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis

Published:2022-01-01 Issue:1 Volume:7 Page:75
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Assimon Magdalene M.¹,Pun Patrick H.²³,Wang Lily (Chin-Hua)⁴,Al-Khatib Sana M.³⁵,Brookhart M. Alan⁶,Weber David J.⁷,Winkelmayer Wolfgang C.⁸,Flythe Jennifer E.¹⁴

Affiliation:

1. University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill

2. Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina

3. Duke Clinical Research Institute, Durham, North Carolina

4. Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill

5. Division of Cardiology, Duke University Medical Center, Durham, North Carolina

6. Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina

7. Division of Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina

8. Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2785156/jamacardiology_assimon_2021_oi_210070_1640293631.01191.pdf

Reference44 articles.

1. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09.;Shapiro;J Antimicrob Chemother,2014

2. Pharmacokinetics and pharmacodynamics of fluoroquinolones.;Drusano;Clin Microbiol Infect,1998

3. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America.;Metlay;Am J Respir Crit Care Med,2019

4. Pharmacokinetics and pharmacodynamics of the new quinolones.;Noreddin;J Pharm Pract.,2005

5. Cardiotoxicity of fluoroquinolones.;Rubinstein;J Antimicrob Chemother,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics of Moxifloxacin‐Related Arrhythmias and Development of a Predictive Nomogram: A Case Control Study;The Journal of Clinical Pharmacology;2024-08-02

2. Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis;JAMA Network Open;2024-04-30

3. Overview of Tendinopathy, Peripheral Neuropathy, Aortic Aneurysm, and Hypoglycemia Caused by Fluoroquinolones;Ibnosina Journal of Medicine and Biomedical Sciences;2024-03-27

4. Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis;Journal of the American Society of Nephrology;2024-02-27

5. Pros and cons of the use of fluoroquinolone antibiotics in patients with kidney disease;Nephrology Dialysis Transplantation;2024-02-08